Edit |   |
---|---|
Antigenic Specificity | CD319 (CRACC), Human |
Clone | REA150 |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 |
Format | PE-Vio 615 conjugate |
Size | 30 tests in 60 µL |
Concentration | 1:50 |
Applications | Flow cytometry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD319 (CRACC) Antibody, anti-human, PE-Vio® 615, REAfinity™. Clone REA150 recognizes CD319, which is a single-pass type I transmembrane protein. CD319 belongs to the SLAM-related receptors (SRRs) family, a subgroup of the CD2 family of Ig-like receptors. Expression of CD319 is found on activated B lymphocytes, natural killer (NK) cells, CD8+T lymphocytes, and mature dendritic cells. The cytoplasmic domain of CD319 contains immunoreceptor tyrosine-based switch motifs (ITSMs), which provide the docking sites for recruitment of small SH2-containing adapter proteins, such as SH2D1A/SLAM-associated protein (SAP) and EWS activated transcript 2 (EAT-2). CD319 displays homophilic interaction and is involved in mediating NK cell cytotoxicity, in the absence of an inhibitory receptor engagement. | Additional information: Clone REA150 displays negligible binding to Fc receptors. | |
Immunogen | n/a |
Other Names | SLAMF7, 19A, CRACC, CS1 |
Gene, Accession # | Gene ID: 57823 |
Catalog # | 130-129-483 |
Price | $166 |
Order / More Info | CD319 (CRACC), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Lee, J. K. et al. (2007) CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J Immunol 179 (7): 4672-4678. | Tassi, I. et al. (2005) The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase C signaling pathways in human NK cells. J Immunol 175: 7996-8002. | Lee, J. K. et al. (2004) Molecular and functional characterization of a CS1 (CRACC) splice variant expressed in human NK cells that does not contain immunoreceptor tyrosine-based switch motifs. Eur. J. Immunol. 34 (10): 2791-2799. |